Access to antiretroviral therapy for adults and children with HIV infection in developing countries: Horizons studies, 2002-2008

Public Health Reports

Volumn 125, Issue 2, 2010, Pages 305-315

  Sarna, Avina ^a   Kellerman, Scott ^b,c  

^a POPULATION COUNCIL   (India)

^b POPULATION COUNCIL   (United States)

^c MANAGEMENT SCIENCES FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ASIA; AWARENESS; CHILD; COMMUNITY; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; AFRICA SOUTH OF THE SAHARA; ARTICLE; CONFIDENTIALITY; CROSS-SECTIONAL STUDY; ETHNOLOGY; HEALTH CARE PLANNING; HEALTH EDUCATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LONGITUDINAL STUDY; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; STATISTICS; UNSAFE SEX;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; CHILD; CONFIDENTIALITY; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; HEALTH EDUCATION; HEALTH PLANNING SUPPORT; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM DEVELOPMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEREOTYPING; UNSAFE SEX;

EID: 77950347696     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491012500221     Document Type: Review

References (45)

1. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report, April 2007 [cited 2008 Feb 12]. Available from: URL: http://searo.who.int/en/Section10/Section18/ Section2008-13202.htm
2. Joint United Nations Programme on HIV/AIDS. 2004 report on the global AIDS epidemic: 4th global report [cited 2008 Feb 10]. Available from: URL: http://www.unaids.org/bangkok2004/GAR2004-pdf/UNAIDSGlobalReport2004-en.pdf
3. Van Dam J, Hutchinson SA. Access to treatment for HIV/AIDS: report of a meeting of international experts, 2001 Jun 12-13, Washington. Horizons Final Report [cited 2008 Mar 10]. Available from: URL: http://www.popcouncil.org/pdfs/ horizons/accesstotreatment.pdf
4. Panpanich R, Sornchai P, Suwanteerangkul KJ, Thamthitiwat S, Sounthisombut P. A rapid situation analysis of the Access to Care Project in northern Thailand. Horizons Final Report. Washington: Population Council; 2004. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/ thaisituationanalysis.pdf [cited 2008 Mar 10].
5. Sarna A, Gupta I, Pujari S, Sengar AK, Garg R, Weiss E. Examining adherence and sexual behavior among patients on antiretroviral therapy in India. Horizons Final Report. Washington: Population Council; 2004. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/indiaart.pdf [cited 2008 Mar 10].
6. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam J. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res 2008;127:28-36.
7. Kiragu K, Schenk K, Murugi J, Sarna A. If you build it, will they come? Kenya healthy start pediatric HIV study: a diagnostic study investigating barriers to HIV treatment and care among children. Horizons Final Report. Washington: Population Council; 2008.
8. Michaels D, Eley B, Ndhlovu L, Rutenberg N. Exploring current practices in pediatric ARV rollout and integration with early childhood programs in South Africa: a rapid situation analysis. Horizons Final Report. Washington: Population Council; 2006. Also available from: URL: http://www.popcouncil.org/ pdfs/horizons/sapedssa.pdf [cited 2008 Mar 10].
9. Ndholvu L, Searle C, Miller R, Fisher A, Snyman E, Sloan N. Reproductive health services in KwaZulu Natal, South Africa: a situation analysis study focusing on HIV/AIDS services. Horizons Final Report. Washington: Population Council; 2003. Also available from: URL: http://www.popcouncil.org/pdfs/ horizons/kznsitanls.pdf [cited 2008 Mar 10].
10. Ndhlovu L, Maphanga T, Madikizela L, Rutenberg N. Exploring models of delivering antiretroviral therapy and integration of ART with TB services in South Africa. Horizons Final Report. Washington: Population Council [forthcoming].
11. Mahendra VS, Mudoi R, Oinam A, Pakkela V, Sarna A, Panda S, et al. Continuum of care for HIV-positive women accessing programs to prevent parent-to-child transmission: findings from India. Horizons Final Report. Washington: Population Council; 2007. Also available from: URL: http://www.popcouncil.org/pdfs/horizons/IndiaPPTCT.pdf [cited 2008 Mar 10].
12. Sarna A, Hawken M, Kaai S. Acceptability of a modified directly observed therapy approach to improve adherence to antiretroviral therapy. Horizons Research Summary. Washington: Population Council; 2004.
13. Horizons/Population Council; International Centre for Reproductive Health; Coast Province General Hospital, Mombasa, Kenya. Adherence to antiretroviral therapy in adults: a guide for trainers. Nairobi: Population Council; 2004.
14. Munyao P, Sarna A, Luchters S, Geibel S, Shikely K, Mandaliya K, et al. How feasible is a DAART strategy to promote adherence to ART? Lessons from Mombasa, Kenya. Horizons Research Update. Nairobi: Population Council; 2005.
15. Sarna A, Luchters S, Geibel S, Chersich MF, Munyao P, Kaai S, et al. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomised trial. J Acquir Immune Defic Syndr 2008;48:611-619
16. Sarna A, Weiss E. Current research and good practice in HIV and AIDS treatment education (UNESCO and WHO, 2007) [cited 2008 Jan 15]. Available from: URL: http://unesdoc.unesco.org/images/0014/001497/149722E.pdf
17. Samuels F, Simbaya J, Sarna A, Giebel S, Ndubani P, Kamwanga J. Engaging communities in supporting HIV prevention and adherence to antiretroviral therapy in Zambia. Horizons Research Summary. Washington: Population Council; 2008.
18. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health 2001;24:518-529
19. Kaai S, Sarna A, Luchters S, Geibel S, Munyao P, Mandaliya K, et al. Changes in stigma among a cohort of people on antiretroviral therapy: findings from Mombasa, Kenya. Horizons Research Update. Nairobi: Population Council; 2007.
20. Sarna A, Luchters S, Kaai S, Munyao P, Geibel S, Shikely K, et al. Does being treated with HAART affect the sexual risk behavior of people living with HIV/AIDS? Insights from Mombasa, Kenya. Horizons Research Update. Nairobi: Population Council; 2005.
21. Sarna A, Luchters SM, Geibel S, Kaai S, Munyao P, Shikely KS, et al. Sexual risk behaviour and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya. Int J STD AIDS 2008;19:85-89
22. Luchters S, Sarna A, Geibel S, Chersich M, Munyao P, Kaai S, et al. Sexual risk behaviors of HIV-positive persons receiving ART in Mombasa, Kenya: longitudinal study findings. Horizons Research Summary. Nairobi: Population Council; 2007.
23. Luchters S, Sarna A, Geibel S, Chersich MF, Munyao P, Kaai S, et al. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: a prospective cohort. AIDS Patient Care STDS 2008;22:587-594
24. Oberdorfer P, Chariyalertsak S, Thapinta D, Suwantherangoon J, Guest P, Wu A, et al. Changes in sexual behavior of people living with HIV after 12 months of antiretroviral therapy: experiences from Thailand. Presented at the 16th International AIDS Conference; 2006 Aug 13-18; Toronto.
25. National Institutes of Health, National Institute of Allergy and Infectious Diseases. Adult AIDS clinical trials group, adult quality of life forms: baseline and follow-up adherence modules [cited 2008 Jan 15]. Available from: URL: https://www.fstrf.org/apps/cfmx/apps/actg/html/QOLForms/index.html
26. Beck AT, Brown GK, Steer RA. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.
27. National Institutes of Health, National Institute of Allergy and Infectious Diseases. Adult AIDS clinical trials group. HR-QOL module [cited 2008 Jan 15]. Available from: URL: https://www.fstrf.org/apps/cfmx/apps/actg/html/ QOLForms/index.html
28. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997;6:481-493
29. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr 2005;38:445-448
30. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-977
31. Miller R, Fisher A, Miller K, Ndhlovu L, Ndugga Maggwa B, Askew I, et al. The situation analysis approach to assessing family planning and reproductive health services: a handbook. New York: Population Council; 1997.
32. Farmer P, Léandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358:404-409
33. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005;353:2325-2334
34. Altice FL, Maru DS, Bruce RD, Springer SA, Friedland GH. Superiority of directly administered antiretroviral therapy over selfadministered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis 2007;45:770-778
35. Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, Walton M, et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis 2004;38 Suppl 5:S376-87.
36. Macalino GE, Mitty JA, Bazerman LB, Singh K, McKenzie M, Flanigan T. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study. Clin Infect Dis 2004;38 Suppl 5:S393-7.
37. Fischl M. Directly observed therapy for HIV therapy in corrections: ready or not? [abstract 528]. Presented at the 8th Conference on Retroviruses and Opportunistic Infections; 2001 Feb 4-8; Chicago.
38. Wohl DA, Stephenson BL, Golin CE, Kiziah CN, Rosen D, Ngo B, et al. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis 2003;36:1572-6.
39. Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis 2006;42:1619-1627
40. Pearson CR, Micek M, Simoni JM, Matediana E, Martin DP, Gloyd S. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr 2006;43 Suppl 1: S134-41.
41. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS 2005;19:1243-1249
42. Bakari AG, Sani-Bello F, Shehu MS, Mai A, Aliyu IS, Lawal II. Antiretroviral therapy induced diabetes in a Nigerian. Afr Health Sci 2007;7:133-135
43. Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, et al. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2007;21:2445-2453
44. Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res 2001;51:151-177
45. William J. Clinton Foundation. Clinton HIV/AIDS Initiative [cited 2008 Aug 18]. Available from: URL: http://www.clintonfoundation.org/what-we-do/ clinton-hiv-aids-initiative